cemdisiran (ALN-CC5) - Alnylam, Regeneron
PiaSky (crovalimab) - Roche
Coversin SC (nomacopan SC) - Akari Therap
Veopoz (pozelimab-bbfg) - Regeneron
Fabhalta (iptacopan) - Novartis
tesidolumab (LFG316) - Novartis
Soliris (eculizumab) - AstraZeneca
Ultomiris (ravulizumab-cwvz) - AstraZeneca
Empaveli (pegcetacoplan SC) - Apellis, SOBI
Zilbrysq (zilucoplan) - UCB
Voydeya (danicopan) - AstraZeneca
https://www.islh.org/virtual/index.php?page=presentation&session_id=21&presentation_id=896&displayday=3&pagefrom=program&preview=
 
Francesco Versino
 
May 9, 2024
 
Prev Next